| Dr Aaron Daniel Coleman, MD | |
|
2006 Franklin St Se Ste 200, Huntsville, AL 35801-4537 | |
| (256) 539-0457 | |
| (256) 539-5827 |
| Full Name | Dr Aaron Daniel Coleman |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 8 Years |
| Location | 2006 Franklin St Se Ste 200, Huntsville, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073960241 | NPI | - | NPPES |
| 285455 | Medicaid | AL | |
| 284537 | Medicaid | AL | |
| 285294 | Medicaid | AL | |
| 288688 | Medicaid | AL | |
| 285733 | Medicaid | AL | |
| 286557 | Medicaid | AL | |
| 284536 | Medicaid | AL | |
| 288788 | Medicaid | AL | |
| 289560 | Medicaid | AL | |
| 285793 | Medicaid | AL | |
| 285799 | Medicaid | AL | |
| 286047 | Medicaid | AL | |
| 286439 | Medicaid | AL | |
| 287380 | Medicaid | AL | |
| 287651 | Medicaid | AL | |
| 284298 | Medicaid | AL | |
| 285186 | Medicaid | AL | |
| 286094 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 64714 (Tennessee) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 36496 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huntsville Hospital | Huntsville, AL | Hospital |
| Crestwood Medical Center | Huntsville, AL | Hospital |
| Athens Limestone Hospital | Athens, AL | Hospital |
| Highlands Medical Center | Scottsboro, AL | Hospital |
| Lawrence Medical Center | Moulton, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Of Huntsville Pc | 2567458359 | 57 |
| Clearview Diagnostic Imaging, Llc | 4486704111 | 26 |
| Radiology Of Huntsville Pc | 2567458359 | 57 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Entity Name | Radiology Of Huntsville Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588621296 PECOS PAC ID: 2567458359 Enrollment ID: O20040426000781 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Entity Name | Sportsmed Orthopaedic Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508947839 PECOS PAC ID: 7214903723 Enrollment ID: O20040907000749 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Entity Name | Insight Imaging Inc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1497713382 PECOS PAC ID: 8820040512 Enrollment ID: O20050210000392 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Entity Name | Clearview Diagnostic Imaging, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164665931 PECOS PAC ID: 4486704111 Enrollment ID: O20090618000072 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Entity Name | Diagnostic Health Mri Of Gadsden, Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1811945306 PECOS PAC ID: 4688560006 Enrollment ID: O20110207000334 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Entity Name | Diagnostic Health Mri Of Gadsden, Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1003151671 PECOS PAC ID: 4688560006 Enrollment ID: O20130109000704 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Entity Name | Diagnostic Health Mri Of Gadsden, Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1407247943 PECOS PAC ID: 4688560006 Enrollment ID: O20180927002513 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Entity Name | Diagnostic Health Mri Of Gadsden, Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1851056188 PECOS PAC ID: 4688560006 Enrollment ID: O20220201001325 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Daniel Coleman, MD 2006 Franklin St Se Ste 200, Huntsville, AL 35801-4537 Ph: (256) 539-0457 | Dr Aaron Daniel Coleman, MD 2006 Franklin St Se Ste 200, Huntsville, AL 35801-4537 Ph: (256) 539-0457 |
News Archive
U.S. Iraq and Afghanistan war veterans (IAVs) with epilepsy were more than twice as likely to die between 2011 and 2015 as were similar veterans without epilepsy. A study published Nov. 11 in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report revealed that IAVs were found to have a higher prevalence of mental and physical comorbidity and to have substantially higher mortality than were veterans without epilepsy.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
› Verified 1 days ago
Dr. Robert Dana Tomalty, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2006 Franklin St Se, Suite 200, Huntsville, AL 35801 Phone: 256-539-0457 Fax: 256-539-5827 | |
Dr. Darrin Lee Johnson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2006 Franklin St Se, Suite 200, Huntsville, AL 35801 Phone: 256-539-0457 Fax: 256-539-5827 | |
Dr. Alex William Johnson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2006 Franklin St Se, Suite 200, Huntsville, AL 35801 Phone: 256-539-0457 Fax: 256-539-5827 | |
Dr. Phillip Dale Bates Jr., MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2006 Franklin St Se Ste 200, Huntsville, AL 35801 Phone: 256-539-0457 | |
Dr. Christopher Jason Green, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2006 Franklin St Se Ste 200, Huntsville, AL 35801 Phone: 256-539-0457 Fax: 256-539-5827 | |
John Thomas Mccarty, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 2006 Franklin St Se Ste 200, Huntsville, AL 35801 Phone: 256-539-0457 |